Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Quants Research Institute HoldingsMAARF +0.20%64 3-Year EBITDA Growth Rate is 38.30% as of Mar. 2026, which is 73% below its 10-year median of 140.10. GuruFocus rates MAARF with a GF Score™ of 64/100 and a GF Value™ of $43.04 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 513 Capital Markets companies, Quants Research Institute Holdings ranks better than 71.73% on this metric.
During the past 12 months, Quants Research Institute Holdings's average EBITDA Per Share Growth Rate was 6.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 38.30% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 229.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Quants Research Institute Holdings was 737.00% per year. The lowest was 38.30% per year. And the median was 140.10% per year.
Quants Research Institute Holdings (OTCPK:MAARF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Quants Research Institute Holdings 3-Year EBITDA Growth Rate Related Terms
MAARF vs MS, GS, SCHW: 3-Year EBITDA Growth Rate Comparison
For the Capital Markets subindustry, Quants Research Institute Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quants Research Institute Holdings 3-Year EBITDA Growth Rate vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, Quants Research Institute Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Quants Research Institute Holdings's 3-Year EBITDA Growth Rate falls into.
Quants Research Institute Holdings 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 38.30% mean?
Quants Research Institute Holdings (MAARF) has a 3-Year EBITDA Growth Rate of 38.30% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Quants Research Institute Holdings and its competitors. This is 73% below median its historical median of 140.10. Over the past decade, Quants Research Institute Holdings' 3-Year EBITDA Growth Rate has ranged from 38.30 to 737.00. According to the industry distribution chart, Quants Research Institute Holdings ranks #145 out of 513 companies in the Capital Markets industry, placing it in the top 28.3%.
Is Quants Research Institute Holdings' 3-Year EBITDA Growth Rate too high?
Quants Research Institute Holdings' current 3-Year EBITDA Growth Rate of 38.30% is 73% below median its 10-year median of 140.10. Over the past 10 years, this metric has ranged from a low of 38.30 to a high of 737.00. The Capital Markets industry median 3-Year EBITDA Growth Rate is 15.20. Quants Research Institute Holdings' value of 38.30% is 152% above this industry median. Based on the distribution chart, Quants Research Institute Holdings ranks #145 out of 513 companies in the Capital Markets industry, which is above the industry midpoint. Overall, Quants Research Institute Holdings has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Quants Research Institute Holdings' 3-Year EBITDA Growth Rate compare to MS and GS?
According to the Capital Markets industry distribution chart, Quants Research Institute Holdings ranks #145 out of 513 companies for 3-Year EBITDA Growth Rate. This puts Quants Research Institute Holdings in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 15.20. Quants Research Institute Holdings' value of 38.30% is 152% above this benchmark. Historically, Quants Research Institute Holdings' own 3-Year EBITDA Growth Rate has ranged from 38.30 to 737.00 over the past decade. While the company's 10-year median is 140.10 vs. the industry median of 15.20, Quants Research Institute Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Capital Markets company?
The median 3-Year EBITDA Growth Rate among Capital Markets companies is 15.20, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quants Research Institute Holdings's current 3-Year EBITDA Growth Rate of 38.30% is 152% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Quants Research Institute Holdings and its competitors. For the Capital Markets industry, the median 3-Year EBITDA Growth Rate is 15.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quants Research Institute Holdings's current 3-Year EBITDA Growth Rate is 38.30%, which is 73% below median its own 10-year median of 140.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quants Research Institute Holdings stock overvalued right now?
Based on GuruFocus' analysis, Quants Research Institute Holdings (MAARF) is currently considered Significantly Undervalued. The stock's GF Value™ is $43.04, compared to a current price of $6.12 — trading 85.8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 38.30%, which is 73% below median its 10-year median of 140.10 and 152% above the Capital Markets industry median of 15.20. Quants Research Institute Holdings' overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Quants Research Institute Holdings (MAARF), the current 3-Year EBITDA Growth Rate is 38.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Quants Research Institute Holdings (MAARF) Overvalued in 2026?
Based on GuruFocus' analysis, Quants Research Institute Holdings stock appears to be undervalued.
The current stock price of $6.12 is trading 85.8% below its estimated GF Value™ of $43.04.
GuruFocus considers Quants Research Institute Holdings to be Significantly Undervalued.
Key valuation signals for MAARF:
3-Year EBITDA Growth Rate: 38.30% (73% below median its 10-year median of 140.10)
GF Value™: $43.04 vs. price of $6.12 (85.8% below fair value)
Industry Position: 152% above the Capital Markets median (#145 of 513)
No single metric tells the full story. See the MAARF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAARF has been successfully added to your 
